VivoSim Labs, Inc.
VIVS
$0.45
-$0.05-10.87%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 40.00K | 26.00K | 28.00K | 37.00K | 51.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.00K | 26.00K | 28.00K | 37.00K | 51.00K |
| Cost of Revenue | 1.13M | 1.14M | 923.00K | 1.00M | 859.00K |
| Gross Profit | -1.09M | -1.11M | -895.00K | -964.00K | -808.00K |
| SG&A Expenses | 2.10M | 1.64M | 1.74M | 1.95M | 2.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.23M | 2.78M | 2.66M | 2.95M | 3.21M |
| Operating Income | -3.19M | -2.75M | -2.64M | -2.92M | -3.15M |
| Income Before Tax | -5.76M | -2.69M | -2.54M | -2.84M | 6.85M |
| Income Tax Expenses | 0.00 | -- | 2.00K | -- | 0.00 |
| Earnings from Continuing Operations | -5.76M | -2.69M | -2.55M | -2.84M | 6.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.76M | -2.69M | -2.55M | -2.84M | 6.85M |
| EBIT | -3.19M | -2.75M | -2.64M | -2.92M | -3.15M |
| EBITDA | -3.14M | -2.70M | -2.58M | -2.85M | -3.09M |
| EPS Basic | -2.19 | -1.03 | -0.98 | -1.14 | 4.21 |
| Normalized Basic EPS | -1.39 | -0.64 | -0.61 | -0.71 | -1.21 |
| EPS Diluted | -2.19 | -1.03 | -0.98 | -1.14 | 4.21 |
| Normalized Diluted EPS | -1.39 | -0.64 | -0.61 | -0.71 | -1.21 |
| Average Basic Shares Outstanding | 2.64M | 2.61M | 2.61M | 2.50M | 1.63M |
| Average Diluted Shares Outstanding | 2.64M | 2.61M | 2.61M | 2.50M | 1.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |